Company intelligence / Profile preview

Blackbird BioVentures

Baltimore, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Blackbird BioVentures is the venture investment arm of Blackbird Laboratories, focused on investing in and accelerating early-stage biotech startups (seed/Series A), particularly those commercializing academic discoveries from Baltimore's leading institutions. Its mission is to build a robust biotech ecosystem in the Baltimore region.

Industry: Investors

Partnerships

Johns Hopkins UniversityUniversity of Maryland, BaltimoreLieber Institute for Brain DevelopmentPTX CapitalInfinity Bio

Beyond the preview

Go deeper on Blackbird BioVentures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blackbird BioVentures.

Explore the full profile